Clinical Trials - Medika Life

If all goes well, thanks to artificial intelligence, we may soon have a new AI-synthesized drug capable of assisting OCD patients in managing their symptoms and thus leading normal lives.

AI is Transforming Health Delivery: A Five-Year Reflection

Gil Bashe, Medika Life Editor - November 20, 2024

Beyond Hype AI, ChatGPT and LLMs Are Practical Tools for Improved Care and Optimized Processes

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI is Transforming Health Delivery: A Five-Year Reflection

Forget Hype – Digital Therapeutic Data Show the Category Can be Held to High Clinical Standards

The Defining Dance Between Empathy and GenAI in Health

It’s Time for New Tools to Overcome Smoking

LATEST

TRENDING

Health Possibilities We Can’t Afford to Block

Texas: Endometriosis Clinical Study Participants – Women’s Health

AI is Transforming Health Delivery: A Five-Year Reflection

Texas: Migraine Clinical Study Participants – Men and Women

Tech Marches On, While Humanity Drags Its Feet

Four Ways COVID has Changed Health Tech

Covid’s Elephant in the Room. We Must Address it

Doctors Find Drug for Lethal Lung Disease After Decades of Trying

Texas: Hot Flashes Clinical Study Participants – Women’s Health

Forget Hype – Digital Therapeutic Data Show the Category Can be Held to High Clinical Standards

EDITORS CHOICE

INOVIO’s COVID-19 Vaccine Shows Durable Antibody and T Cell Responses

Covid’s Elephant in the Room. We Must Address it

First Drug Synthesized by AI Goes into Clinical Trials

AI is Transforming Health Delivery: A Five-Year Reflection

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories